Literature DB >> 14045347

THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES.

H G KELLY, J E FAY, S G LAVERTY.   

Abstract

Twenty-eight electrocardiograms are presented which depict a quinidine-like effect of thioridazine on ventricular repolarization, in doses as low as 200 mg. a day. T waves have been found to flatten out and sometimes invert. Occasionally S-T segments have become convex and U waves have appeared.Case reports are presented of two patients who died while receiving large doses of thioridazine, 1500 and 3600 mg. daily, respectively. Terminal ECG patterns in each instance were those of heart block, alternating with episodes of ventricular tachycardia.The myocardium of one of the fatal cases revealed edema, increased vascularity, and some increase in connective tissue elements, along with fragmentation of muscle fibers. These changes were most pronounced in the interventricular septum.It is concluded that, because of the quinidine-like action of thioridazine on ventricular repolarization, caution is indicated when it is administered in large doses.

Entities:  

Keywords:  ELECTROCARDIOGRAPHY; HEART BLOCK; PATHOLOGY; SHOCK, TOXIC; TACHYCARDIA; THIORIDAZINE; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1963        PMID: 14045347      PMCID: PMC1921808     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  Pigmentary retinopathy in patients receiving high doses of a new phenothiazine.

Authors:  R D WEEKLEY; A M POTTS; J REBOTON; R H MAY
Journal:  Arch Ophthalmol       Date:  1960-07

2.  Antiarrhythmics. XII. Anti-arrhythmic activity of some phenothiazine derivatives in experimental cardiac arrhythmias.

Authors:  P L SHARMA; R B ARORA
Journal:  Indian J Med Res       Date:  1961-11       Impact factor: 2.375

  2 in total
  37 in total

1.  Arrhythmias and sudden death in patients taking antipsychotic drugs.

Authors:  Andrew Herxheimer; David Healy
Journal:  BMJ       Date:  2002-11-30

Review 2.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  THIORIDAZINE AND ELECTROCARDIOGRAPHIC ABNORMALITIES.

Authors:  M H WENDKOS
Journal:  Can Med Assoc J       Date:  1963-12-21       Impact factor: 8.262

4.  Phenothiazines and the electrocardiogram.

Authors:  M V Jeeva Raj; R Benson
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

5.  Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

Authors:  Charles E Leonard; Cristin P Freeman; Craig W Newcomb; Warren B Bilker; Stephen E Kimmel; Brian L Strom; Sean Hennessy
Journal:  J Clin Exp Cardiolog       Date:  2013

6.  Ziprasidone and hypokalemia: a case of 2 predisposing factors for QTc prolongation without development of torsades de pointes.

Authors:  B Rush Simpson; Robert P Albanese
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 7.  Psychotropic medication use for behavioral symptoms of dementia.

Authors:  Philip S Wang; M Alan Brookhart; Soko Setoguchi; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

8.  Phenothiazine induced ventricular tachycardia.

Authors:  T B Tri; D T Combs
Journal:  West J Med       Date:  1975-11

Review 9.  Thioridazine: resurrection as an antimicrobial agent?

Authors:  H K R Thanacoody
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

10.  The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Authors:  Jason G Ho; Randall L Caldwell; Christopher J McDougle; Danielle K Orsagh-Yentis; Craig A Erickson; David J Posey; Kimberly A Stigler
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.